Steffen Löck
Steffen Löck
OncoRay - National Center of Radiation Research in Oncology
Verified email at - Homepage
Cited by
Cited by
The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping
A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ...
Radiology 295 (2), 328-338, 2020
Image biomarker standardisation initiative
A Zwanenburg, S Leger, M Vallières, S Löck
arXiv preprint arXiv:1612.07003, 2016
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
S Leger, A Zwanenburg, K Pilz, F Lohaus, A Linge, K Zöphel, J Kotzerke, ...
Scientific reports 7 (1), 13206, 2017
Assessing robustness of radiomic features by image perturbation
A Zwanenburg, S Leger, L Agolli, K Pilz, EGC Troost, C Richter, S Löck
Scientific reports 9 (1), 614, 2019
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a …
F Lohaus, A Linge, I Tinhofer, V Budach, E Gkika, M Stuschke, ...
Radiotherapy and oncology 113 (3), 317-323, 2014
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary …
A Linge, F Lohaus, S Löck, A Nowak, V Gudziol, C Valentini, ...
Radiotherapy and Oncology 121 (3), 364-373, 2016
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
S Löck, R Perrin, A Seidlitz, A Bandurska-Luque, S Zschaeck, K Zöphel, ...
Radiotherapy and Oncology 124 (3), 533-540, 2017
Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV (−) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG
A Linge, S Löck, V Gudziol, A Nowak, F Lohaus, C von Neubeck, M Jütz, ...
Clinical cancer research 22 (11), 2639-2649, 2016
Image biomarker standardisation initiative-feature definitions
A Zwanenburg, S Leger, M Vallières, S Löck
arXiv preprint arXiv:1612.07003 10, 2016
Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis
A Jakobi, A Bandurska-Luque, K Stützer, R Haase, S Löck, LJ Wack, ...
International Journal of Radiation Oncology* Biology* Physics 92 (5), 1165-1174, 2015
Dynamical tunneling in mushroom billiards
A Bäcker, R Ketzmerick, S Löck, M Robnik, G Vidmar, R Höhmann, U Kuhl, ...
Physical review letters 100 (17), 174103, 2008
Regular-to-chaotic tunneling rates: From the quantum to the semiclassical regime
S Löck, A Bäcker, R Ketzmerick, P Schlagheck
Physical review letters 104 (11), 114101, 2010
Regular-to-chaotic tunneling rates using a fictitious integrable system
A Bäcker, R Ketzmerick, S Löck, L Schilling
Physical review letters 100 (10), 104101, 2008
Predicting late magnetic resonance image changes in glioma patients after proton therapy
J Eulitz, EGC Troost, F Raschke, E Schulz, B Lutz, A Dutz, S Löck, ...
Acta Oncologica 58 (10), 1536-1539, 2019
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
A Mukha, U Kahya, A Linge, O Chen, S Löck, V Lukiyanchuk, S Richter, ...
Theranostics 11 (16), 7844, 2021
Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure
S Zschaeck, R Haase, N Abolmaali, R Perrin, K Stützer, S Appold, ...
Acta Oncologica 54 (9), 1355-1363, 2015
Prognostic value of pretherapeutic tumor-to-blood standardized uptake ratio in patients with esophageal carcinoma
R Bütof, F Hofheinz, K Zöphel, T Stadelmann, J Schmollack, C Jentsch, ...
Journal of Nuclear Medicine 56 (8), 1150-1156, 2015
Quality factors and dynamical tunneling in annular microcavities
A Bäcker, R Ketzmerick, S Löck, J Wiersig, M Hentschel
Physical Review A 79 (6), 063804, 2009
The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity
D Digomann, I Kurth, A Tyutyunnykova, O Chen, S Löck, I Gorodetska, ...
Clinical Cancer Research 25 (10), 3152-3163, 2019
Why validation of prognostic models matters?
A Zwanenburg, S Löck
Radiotherapy and Oncology 127 (3), 370-373, 2018
The system can't perform the operation now. Try again later.
Articles 1–20